R. Burrer, Neuman, B. W., Ting, J. P. C., Stein, D. A., Moulton, H. M., Iversen, P. L., Kuhn, P., and Buchmeier, M. J.,
“Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models.”,
Journal of virology, vol. 81, no. 11, pp. 5637-48, 2007.
M. H. Nelson, Stein, D. A., Kroeker, A. D., Hatlevig, S. A., Iversen, P. L., and Moulton, H. M.,
“Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity.”,
Bioconjugate chemistry, vol. 16, no. 4, pp. 959-66, 2005.
B. Lebleu, Moulton, H. M., Abes, R., Ivanova, G. D., Abes, S., Stein, D. A., Iversen, P. L., Arzumanov, A. A., and Gait, M. J.,
“Cell penetrating peptide conjugates of steric block oligonucleotides.”,
Advanced drug delivery reviews, vol. 60, no. 4-5, pp. 517-29, 2008.
B. W. Neuman, Bederka, L. H., Stein, D. A., Ting, J. P. C., Moulton, H. M., and Buchmeier, M. J.,
“Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors.”,
Antimicrobial agents and chemotherapy, vol. 55, no. 10, pp. 4631-8, 2011.
B. W. Neuman, Stein, D. A., Kroeker, A. D., Moulton, H. M., Bestwick, R. K., Iversen, P. L., and Buchmeier, M. J.,
“Inhibition and escape of SARS-CoV treated with antisense morpholino oligomers.”,
Advances in experimental medicine and biology, vol. 581, pp. 567-71, 2006.
C. Lupfer, Stein, D. A., Mourich, D. V., Tepper, S. E., Iversen, P. L., and Pastey, M.,
“Inhibition of influenza A H3N8 virus infections in mice by morpholino oligomers.”,
Archives of virology, vol. 153, no. 5, pp. 929-37, 2008.
Q. Ge, Pastey, M., Kobasa, D., Puthavathana, P., Lupfer, C., Bestwick, R. K., Iversen, P. L., Chen, J., and Stein, D. A.,
“Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers.”,
Antimicrobial agents and chemotherapy, vol. 50, no. 11, pp. 3724-33, 2006.